Followers | 751 |
Posts | 16572 |
Boards Moderated | 1 |
Alias Born | 05/30/2007 |
Tuesday, March 09, 2021 10:19:50 AM
Security $LGNXZ / Ligand Pharmaceuticals Incorporated Glucagon Contingent Value (53220K181)
President & CEO HIGGINS JOHN L
ISIN US53220K1815
LEI 5493008K7TB0IKP37H79
Industry Pharmaceutical Preparations
Institutional Owners 10
Institutional Shares 469,446 - 8% (ex 13D/G)
Related
$LGND / Ligand Pharmaceuticals Incorporated (626 owners)
$LGNZZ / Ligand Pharmaceuticals Incorporated Beta Contingent Value (6 owners)
$LGNYZ / Ligand Pharmaceuticals Incorporated General Contingent Value (6 owners)
$LGNDZ / Ligand Pharmaceuticals Incorporated Roche Contingent Value (8 owners)
Institutional Ownership and Shareholders
$LGNXZ / Ligand Pharmaceuticals Incorporated Glucagon Contingent Value Institutional Ownership
Ligand Pharmaceuticals Incorporated Glucagon Contingent Value (US: $LGNXZ) has 10 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 469,446 shares. Largest shareholders include VEXMX - Vanguard Extended Market Index Fund Investor Shares, Group One Trading, L.p., KINETICS PORTFOLIOS TRUST - Kinetics Medical Portfolio, Group One Trading, L.p., FSMAX - Fidelity Extended Market Index Fund, ONEQ - Fidelity Nasdaq Composite Index Tracking Stock, FNCMX - Fidelity Nasdaq Composite Index Fund, Captrust Financial Advisors, Simplex Trading, Llc, and Simplex Trading, Llc.
Ligand Pharmaceuticals Incorporated Glucagon Contingent Value (US: $LGNXZ) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%.
Institutional Put/Call Ratio
In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.
Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.
13D/G Filings
We present 13D/G filings separately from the 13F filings because of the different treatement by the SEC. 13D/G filings can be filed by groups of investors (with one leading), whereas 13F filings cannot. This results in situations where an investor may file a 13D/G reporting one value for the total shares (representing all the shares owned by the investor group), but then file a 13F reporting a different value for the total shares (representing strictly their own ownership). This means that share ownership of 13D/G filings and 13F filings are oftentimes not directly comparable, so we present them separately.
13F and Fund Filings
Detail on 13F filings are free. Detail on NP filings require a premium membership. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
Effective Date:
2021-03-01 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares 395,811
2021-02-26 NP KINETICS PORTFOLIOS TRUST - Kinetics Medical Portfolio 44,000
2021-02-16 13F Captrust Financial Advisors 500
2021-01-20 NP FNCMX - Fidelity Nasdaq Composite Index Fund 1,518
2021-01-20 NP FSMAX - Fidelity Extended Market Index Fund 26,087
2021-01-20 NP ONEQ - Fidelity Nasdaq Composite Index Tracking Stock 1,530
Link: https://fintel.io/so/us/lgnxz
Recent LGND News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 06:27:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:28:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 11:12:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:09:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:50:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:50:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:50:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:49:56 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 02/29/2024 09:49:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 11:05:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/28/2024 10:43:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 12:24:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:10:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:10:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:10:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/17/2024 01:10:16 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 11:26:25 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 08:39:23 PM
- Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene • GlobeNewswire Inc. • 01/11/2024 12:30:00 AM
- Ligand Pharmaceuticals Gets FDA OK for Viral Skin Infection Treatment • Dow Jones News • 01/05/2024 10:40:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:07:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:07:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 08:27:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 08:27:13 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM